theMednet - In what situation would you choose to monitor a recurrent

Community
Company
News
Contact Us
Sign in

Topics: Breast Cancer • Medical Oncology • Breast Cancer, Non-metastatic • hormone receptor + • DCIS

In what situation would you choose to monitor a recurrent < 1 cm DCIS with hormone therapy alone?

Recurrence occurred 1 year after lumpectomy and patient did not receive adjuvant radiation or hormone suppression after the first DCIS. Surgeon would like to monitor on AI with q6 month mammo.

Related Questions

How do you approach ovarian function suppression in premenopausal women with HR+/HER2-, node negative breast cancer and intermediate OncoType dx scores (11-25) who received chemotherapy?

How would you discuss the prognosis of HR-positive early breast cancer in an elderly >90 patient who elects against surgery in favor of endocrine treatment only?

Would you give KEYNOTE 522 in combination with trastuzumab/pertuzumab neoadjuvantly for multifocal disease?

How do you approach treatment for a patient with T2N0, ER+/PR+, HER2 negative breast cancer with planned TC treatment following a hypersensitivity reaction?

What is your treatment approach in a patient with cT2 ER+HER2+ who refuses neoadjuvant chemotherapy?

For which patients, if any, do you typically order additional imaging workup for staging in early-stage breast cancer?

Would you provide anthracycline-based therapy for early stage node negative triple-negative breast cancer in patient with echocardiogram showing grade 1 diastolic dysfunction?

How would you treat rapidly growing inflammatory breast cancer, invasive lobular triple negative subtype, after two cycles of neoadjuvant keynote 522?

Would you offer systemic therapy (TH) to a patient with HER2+ (3+), HR- high grade microinvasive breast cancer with single focus or multifocal?

Would you offer adjuvant endocrine therapy to a male with ER+ DCIS?